bearish
Aier Eye Hospital Group
Aier Eye Hospital Group (300015.CH) - More than Just Bribery Scandal
The recent bribery scandal of Aier has raised widespread concern,but may not fundamentally overturn Aier.The biggest risk is the revolutionary technology/drugs to form a "dimensional reduction attack"
Equity Bottom-Up
259 Views, 20 Jan 2022 09:11
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- Unlimited Research Summaries
- Personalised Alerts
- Custom Watchlists
- Company Analytics & News
- Events & Webinars
Trusted by:
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Aier Eye Hospital Group (300015.CH) 2021/2022Q1 Results - Overvaluation and a Risky Outlook18 May 2022
- Hygeia Healthcare Group (6078.HK) 2021 Results - Solid Business Logic Comes with Policy Risk20 Apr 2022
- Pre IPO Ascent ENT Group Holdings - Conservative About the Outlook10 Mar 2022
- Aier Eye Hospital Group (300015.CH) - More than Just Bribery Scandal20 Jan 2022
- The Insecure Rebound in Healthcare Sector and the Future Direction of Stock Price (2022)17 Jan 2022
- The Concerns and Outlook About the Recent Rally in Traditional Chinese Medicine (TCM) Sector06 Jan 2022
- China Healthcare Weekly (Dec.31)-1st State-Level Device Policy,TCM Guideline,TCM Rally Unsustainable02 Jan 2022
- Aier Eye Hospital Group (300015.CH) - The Concerns Behind the High Growth Momentum28 Sep 2021
- Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential09 Dec 2020
x